Gastrointestinal Fellowship
Overview
The gastrointestinal (GI) radiation oncology team at Princess Margaret Cancer Centre represents decades of cancer expertise involving an internationally renowned radiation oncology team of pioneering radiation oncology physicians, medical physicists, dosimetrists, radiation therapists, and nurses, working together with the broader multi-disciplinary GI group to provide integrated, streamlined care for every patient.
GI clinical services
The GI group in the Radiation Medicine Program treats all stages and categories of GI cancers, including rare, difficult-to-treat, and advanced-stage malignancy of the upper GI (esophagus and stomach), hepatobilliary cancer (liver, bile duct and pancreas), lower GI (colorectal and anal cancer), as well as stereotactic body radiation therapy (SBRT) for liver and abdominal oligometastasis and oligoprogression.
State-of-art technology
We offer the latest in advanced radiation therapy technology, including intensity-modulated radiation therapy (IMRT), volumetric modulated arch therapy (VMAT), image-guided radiation therapy (IGRT), SBRT, and MR-linac guided radiation therapy.
Multidisciplinary comprehensive care
Our program works within the Comprehensive Cancer Center’s multidisciplinary services to meet individual patients’ needs. Multidisciplinary cancer conferences are attended by GI-subspecialized radiation oncologists, medical oncologists, surgical oncologists, radiologists, pathologist, and support staff for clinical care. We discuss and review challenging and new GI clinical cases and derive consensus regarding optimal management decision for each case. This cross-specialty approach enables us to provide comprehensive care tailored to each patient’s needs.
Clinical trials
We are constantly working to improve patient outcomes in all GI cancers. Offering many clinical trials, aiming to improve the effectiveness of radiation therapy with fewer side effects. These trials range from early phase trails of innovative applications of radiation therapy with or without systemic therapy to practice changing randomized controlled trials.